Use of Rituximab Compared to Anti-TNF Agents as Second and Third Line Therapy in Patients with Rheumatoid Arthritis. A 6 Year Follow-Up Report from the Rhumadata Clinical Database and Registry
作者:
发布时间
2019-08-16
- 浏览0

The Journal of rheumatology
1212-1213页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文